Articles from Market News Alerts

Market News Alerts Updates: Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. B2B2C recurring revenue surged 398% year-over-year to $5.6 million in Q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care platform. Gross margins in the B2B2C business exceeded 80% over the past three quarters.

Market News Alerts Reports: Nuvectis Pharma (NASDAQNVCT)* announced today that new independent research conducted at the Lerner Research Institute, Cleveland Clinic (at Case Western Reserve University) has demonstrated the superior efficacy of NXP900 when combined with osimertinib (Tagrisso®) in EGFR-mutated non-small cell lung cancer (NSCLC) models. The peer-reviewed study, published in Molecular Cancer Research, demonstrated that the combination therapy led to decreased cancer cell proliferation and increased apoptosis compared to osimertinib alone.

Market News Alerts Reports: Lucid Capital Markets has initiated coverage on Nuvectis Pharma (Nasdaq: NVCT) with a Buy rating and a price target of $18. The firm's report highlights Nuvectis' promising oncology pipeline, particularly its lead asset, NXP900, a SRC/YES1 inhibitor targeting squamous cell carcinomas with high unmet need.

Market News Alerts Updates: DarioHealth Corp. (Nasdaq: DRIO)* has announced a significant new agreement with a Blue Cross Blue Shield (BCBS) health plan, marking a pivotal expansion in the fast-growing digital health landscape. This move integrates Dario's AI-driven cardiometabolic digital health solutions, covering diabetes, hypertension, and weight management, into the offerings of one of America’s most trusted health insurers. According to a recent report, the cardiometabolic disease market is projected to surpass $1.2 trillion by 2033.

Market News Alerts Reports: Actelis Networks* (NASDAQASNS), a leader in cyber-hardened networking solutions, has appointed Dr. Niel Ransom to its Board of Directors. A veteran with nearly five decades in networking, cybersecurity, and deep-tech investment, Ransom brings critical expertise as demand for secure, high-performance networks surges. His appointment follows Actelis’ recent launch of MetaShield, an AI-powered cybersecurity solution designed to protect critical infrastructure at the network edge.

Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The company’s latest move expands its GLP-1 offering with prescribing capabilities, positioning Dario to capture a larger share of this lucrative space as demand for medical weight-loss solutions skyrockets across employers and consumers. Following the announcement, Dario’s shares surged nearly 14%, reflecting investor excitement over this significant growth opportunity.

Market News Alerts updates that Litchfield Hills analyst Theodore O’Neill initiated coverage of Actelis Networks (Nasdaq:ASNS). The firm’s price target on Actelis Networks is $5 and the firm gave Actelis’ stock a buy rating. The report emphasizes Actelis’ global reach, serving over 300 customers across 30 countries, and its blue-chip client list that includes government agencies, transportation authorities, and defense organizations. Notably, recent deployments, such as modernizing Washington, D.C.'s traffic network, show the reliability and versatility of its solutions. The report further highlights Actelis' "well-protected technology moat," supported by 31 granted U.S. patents and proprietary trade secrets, which give the company a unique edge in a competitive market. The report also noted Actelis’ "Cyber Aware Networking" initiative, which integrates AI-driven cybersecurity into its networking solutions.